Intracellular delivery of siRNA by cell-penetrating peptides modified with cationic oligopeptides

References

• Patil SD, Rhodes DG, Burgess DJ. (2005). DNA-based therapeutics and DNA delivery systems: a comprehensive review. AAPS J, 7, E61–77.
   PubMed Web of Science ®Google Scholar
• Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 411, 494–8.
   PubMed Web of Science ®Google Scholar
• Paula DD, Bentley MV, Mahato RI. (2007). Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting. RNA, 13, 431–56.
   PubMed Web of Science ®Google Scholar
• Derossi D, Joliot AH, Chassaing G, Prochiantz A. (1994). The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem, 269, 10444–50.
   PubMed Web of Science ®Google Scholar
• Pujals S, Fernández-Carneado J, López-Iglesias C, Kogan MJ, Giralt E. (2006). Mechanistic aspects of CPP-mediated intracellular drug delivery: relevance of CPP self-assembly. Biochim Biophys Acta, 1758, 264–79.
   PubMed Web of Science ®Google Scholar
• Patel LN, Zaro JL, Shen WC. (2007). Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives. Pharm Res, 24, 1977–92.
   PubMed Web of Science ®Google Scholar
• El-Andaloussi S, Järver P, Johansson HJ, Langel U. (2007). Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study. Biochem J, 407, 285–92.
   PubMed Web of Science ®Google Scholar
• Abes S, Moulton H, Turner P, Clair P, Richard JP, Iversen P, Gait MJ, Lebleu B. (2007). Peptide-based delivery of nucleic acids: design, mechanism of uptake and applications to splice- correcting oligonucletides. Biochem Soc Trans, 35, 53–5.
   PubMed Web of Science ®Google Scholar
• Zhang C, Tang N, Liu X, Liang W, Xu W, Torchilin VP. (2006). siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene. J Contr Rel, 112, 229–39.
   PubMed Web of Science ®Google Scholar
• Kang H, DeLong R, Fisher MH, Juliano RL. (2005). Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides. Pharm Res, 22, 2099–106.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Kogure K, Futaki S, Harashima H. (2007). Octaarginine-modified multifunctional envelope-type nano device for siRNA. J Contr Rel, 119, 360–7.
   PubMed Web of Science ®Google Scholar
• Davidson TJ, Harel S, Arboleda VA, Prunell GF, Shelanski ML, Greene LA, Troy CM. (2004). Highly efficient small interfering RNA delivery to primary mammalian neurons induces MicroRNA-like effects before mRNA degradation. J Neurosci, 24, 10040–6.
   PubMed Web of Science ®Google Scholar
• Muratovska A, Eccles MR. (2004). Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells. FEBS Lett, 558, 63–8.
   PubMed Web of Science ®Google Scholar
• Turner JJ, Jones S, Fabani MM, Ivanova G, Arzumanov AA, Gait MJ. (2007). RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA. Blood Cells Molec Dis, 38, 1–7.
   PubMed Web of Science ®Google Scholar
• Chiu YL, Ali A, Chu CY, Cao H, Rana TM. (2004). Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells. Chem Biol, 11, 1165–75.
   PubMed Web of Science ®Google Scholar
• Meade BR, Dowdy SF. (2007). Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides. Adv Drug Deliv Rev, 59, 134–40.
   PubMed Web of Science ®Google Scholar
• Jiang T, Olson ES, Nguyen QT, Roy M, Jennings PA, Tsien RY. (2004). Tumor imaging by means of proteolytic activation of cell- penetrating peptides. Proc Natl Acad Sci USA, 101, 17867–72.
   PubMed Web of Science ®Google Scholar
• Unnamalai N, Kang BG, Lee WS. (2004). Cationic oligopeptide- mediated delivery of dsRNA for post-transcriptional gene silencing in plant cells. FEBS Lett, 566, 307–10.
   PubMed Web of Science ®Google Scholar
• Wang YH, Hou YW, Lee HJ. (2007). An intracellular delivery method for siRNA by an arginine-rich peptide. J Biochem Biophys Methods, 70, 579–86.
   PubMedGoogle Scholar
• Simeoni F, Morris MC, Heitz F, Divita G. (2003). Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. Nucleic Acids Res, 31, 2717–24.
   PubMed Web of Science ®Google Scholar
• Veldhoen S, Laufer SD, Trampe A, Restle T. (2006). Cellular delivery of small interfering RNA by a non-covalently attached cell- penetrating peptide: quantitative analysis of uptake and biological effect. Nucleic Acids Res, 34, 6561–73.
   PubMed Web of Science ®Google Scholar
• Lundberg P, El-Andaloussi S, Sütlü T, Johansson H, Langel U. (2007). Delivery of short interfering RNA using endosomolytic cell-penetrating peptides. FASEB J, 21, 2664–71.
   PubMed Web of Science ®Google Scholar
• Soomets U, Lindgren M, Gallet X, Hallbrink M, Elmquist A, Balaspiri L, Zorko M, Pooga M, Brasseur R, Langel U. (2000). Deletion analogues of transportan. Biochim Biophys Acta, 1467, 165–76.
   PubMed Web of Science ®Google Scholar
• Vivès E, Brodin P, Lebleu B. (1997). A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem, 272, 16010–7.
   PubMed Web of Science ®Google Scholar
• Saar K, Lindgren M, Hansen M, Eiríksdóttir E, Jiang Y, Rosenthal-Aizman K, Sassian M, Langel U. (2005). Cell-penetrating peptides: a comparative membrane toxicity study. Anal Biochem, 345, 55–65.
   PubMed Web of Science ®Google Scholar
• Mescalchin A, Detzer A, Wecke M, Overhoff M, Wünsche W, Sczakiel G. (2007). Cellular uptake and intracellular release are major obstacles to the therapeutic application of siRNA: novel options by phosphorothioate-stimulated delivery. Expert Opin Biol Ther, 7, 1531–8.
   PubMed Web of Science ®Google Scholar
• Berezhna SY, Supekova L, Supek F, Schultz PG, Deniz AA. (2006). siRNA in human cells selectively localizes to target RNA sites. Proc Natl Acad Sci USA, 103, 7682–7.
   PubMed Web of Science ®Google Scholar
• Leng Q, Goldgeier L, Zhu J, Cambell P, Ambulos N, Mixson AJ. (2007). Histidine-lysine peptides as carriers of nucleic acids. Drug News Perspect, 20, 77–86.
   PubMed Web of Science ®Google Scholar
• Leng Q, Mixson AJ. (2005). Modified branched peptides with a histidine-rich tail enhance in vitro gene transfection. Nucleic Acids Res, 33, e40.
   PubMed Web of Science ®Google Scholar
• Wagner E, Plank C, Zatloukal K, Cotten M, Birnstiel ML. (1992). Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. Proc Natl Acad Sci USA, 89, 7934–8.
   PubMed Web of Science ®Google Scholar